PP_1170x120_10-25-21

neomycin sulfate tablets

Lannett cleared to market neomycin sulfate tablets

Lannett cleared to market neomycin sulfate tablets

PHILADELPHIA — Lannett Co. has gained approval from the Food and Drug Administration for neomycin sulfate tablets 500 mg, an antibiotic. Lannett said Monday that its product is a therapeutic equivalent to the reference listed drug, neomycin sulfate tablets (500 mg) from Teva Pharmaceuticals USA Inc. “The approval for neomycin sulfate Tablets expands our portfolio